FDA approval does not really mean much without insurance coverage. That really hurts exact sciences. That was also a killer for Radient when DR70 was not covered by insurance.
Our RXPC merger theorists bought AMBS in 2013 -- April, I believe.
* If you spent $5000 on AMBS in April 2013, today you'd have $807 * If you spent $5000 on RXPC in April 2013, today you'd have $0 * If you spent $5000 on EXAS in April 2013, today you'd have $6950
Yet our merger theorists are gloating about the current PPS drop of EXAS. How very odd.